Abstract
Bipolar, epilepsy and migraine disorders are frequently reported as co-morbid conditions. In this review article we highlight some of the similarities between these disorders, exploring at various levels including cellular, structural and phenotypic changes. Clinical observations suggest considerable overlap with a number of common neurobiological features. Nonetheless, the courses of development of each disorder remain to be elucidated such that there is much room for further research into their precise underlying mechanisms. A better understanding of the neurobiology of these disorders will help to improve current treatments, particularly when there is co-morbidity and presence of treatment resistant and complex cases.
Keywords: Bipolar disorder, comorbidity, depressive disorders, epilepsy, migraine, psychopharmacology.
Current Psychopharmacology
Title:Bipolar Affective Disorder, Epilepsy and Migraine – Does Possible Shared Pathogenesis Explain their Association?
Volume: 2
Author(s): Jonathon Holland, Mark Agius and Rashid Zaman
Affiliation:
Keywords: Bipolar disorder, comorbidity, depressive disorders, epilepsy, migraine, psychopharmacology.
Abstract: Bipolar, epilepsy and migraine disorders are frequently reported as co-morbid conditions. In this review article we highlight some of the similarities between these disorders, exploring at various levels including cellular, structural and phenotypic changes. Clinical observations suggest considerable overlap with a number of common neurobiological features. Nonetheless, the courses of development of each disorder remain to be elucidated such that there is much room for further research into their precise underlying mechanisms. A better understanding of the neurobiology of these disorders will help to improve current treatments, particularly when there is co-morbidity and presence of treatment resistant and complex cases.
Export Options
About this article
Cite this article as:
Holland Jonathon, Agius Mark and Zaman Rashid, Bipolar Affective Disorder, Epilepsy and Migraine – Does Possible Shared Pathogenesis Explain their Association?, Current Psychopharmacology 2013; 2 (2) . https://dx.doi.org/10.2174/2211556011302020001
DOI https://dx.doi.org/10.2174/2211556011302020001 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors
Current Drug Metabolism Potential for Discovery of Neuroprotective Factors in Serum and Tissue from Hibernating Species
Mini-Reviews in Medicinal Chemistry Mining for Protein Kinase Substrates: Integration of Biochemistry, Genetics and Proteomics
Current Proteomics Synthesis, Antifungal Activity and Carbonic Anhydrase Inhibitory Properties of Cu (II) Bis (3, 4 Dimethoxybenzoate) Bis (Nicotinamide) Dihydrate
Current Enzyme Inhibition Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Current Neuropharmacology Pharmacological Characterization of Ligands at Recombinant NMDA Receptor Subtypes by Electrophysiological Recordings and Intracellular Calcium Measurements
Combinatorial Chemistry & High Throughput Screening Antiepileptic Drugs for Preventing Seizures in Patients with Chronic Subdural Hematoma
Current Pharmaceutical Design Targeting Voltage-Gated Sodium Channels for Treating Neuropathic and Inflammatory Pain
Current Pharmaceutical Biotechnology Pharmacology of Ultrasonic Vocalizations in adult Rats: Significance, Call Classification and Neural Substrate
Current Neuropharmacology Potential Phytotherapeutic Approaches for the Treatment of Alzheimer’s Disease: An Overview
Current Traditional Medicine The Role of P-Glycoprotein in Psychiatric Disorders: A Reliable Guard of the Brain?
Central Nervous System Agents in Medicinal Chemistry Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
Current Nanomedicine Polymer Drug Conjugates: Recent Advancements in Various Diseases
Current Pharmaceutical Design Astrocyte-Neuron Interaction at Tripartite Synapses
Current Drug Targets Migraine and Central Sensitization: Clinical Features, Main Comorbidities and Therapeutic Perspectives
Current Rheumatology Reviews Potassium Channels and CNS Diseases
CNS & Neurological Disorders - Drug Targets High Throughput Screening Methodologies Classified for Major Drug Target Classes According to Target Signaling Pathways
Combinatorial Chemistry & High Throughput Screening Pharmacological Screening of Lantana camara for its Antiallergic Activity in Rodents
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) The Biology of the RNA Binding Protein Guanine-Rich Sequence Binding Factor 1
Current Protein & Peptide Science Global Expression Studies of Schizophrenic Brain: A Meta-Analysis Study Linking Neurological Immune System with Psychological Disorders
CNS & Neurological Disorders - Drug Targets